NCT02486666View on ClinicalTrials.gov

Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose

PHASE3UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Venous Thromboembolism
Interventions
DRUG

Enoxaparin

WEIGHT ADJUSTED FiXED DOSE OF LOW MOLECULAR WEIGHT HEPARIN (ENOXAPARIN) TO NEONATES AND CHILDREN WITH THROMBOSIS (FiXET)

Trial Locations (4)

19104

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

B3K 6R8

RECRUITING

IWK Health Center, Halifax

L8N3Z5

RECRUITING

HHSC/McMaster Children's Hospital, Hamilton

K1H 8L1

NOT_YET_RECRUITING

Children's Hospital of Eastern Ontario, Ottawa

Sponsors

Collaborators (1)

IWK Health Centre
All Listed Sponsors
collaborator

IWK Health Centre

OTHER

collaborator

Children's Hospital of Philadelphia

OTHER

collaborator

Children's Hospital of Eastern Ontario

OTHER

lead

Hamilton Health Sciences Corporation

OTHER